(A) Overlay of CEx chromatographic profile of INTP5, US Neulasta and EU Neulasta (Sample I2, U4 and E2); (B) Representative CEx-HPLC profile of INTP5 (Sample I2).</p
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
(A) Overlay of SEC-HPLC chromatographic profile of INTP5, US Neulasta and EU Neulasta (Sample I2, U4...
(A) Overlay of RP chromatographic profile of INTP5, US Neulasta and EU Neulasta (Sample I2, U4 and E...
(A) Overlay of far UV CD spectra, (B) Overlay of FTIR spectra, (C) Overlay of fluorescence spectra, ...
(A) Representative RP-HPLC profile of stressed deamidated INTP5 (Sample I2) for peak collection. (Hi...
(A) Representative RP-HPLC profile of oxidized (24 hours) INTP5 Sample I2 (B) Overlay of control sam...
(A) TIC overlay of pegfilgrastim main peak and Pre-peak impurity (RRT 0.84) in peptide mapping (10–7...
(A) TIC overlay of pegfilgrastim main peak and Pre-peak impurity 1 (RRT 0.60) in peptide mapping (10...
The approval of biosimilars requires demonstration of biosimilarity, which rests on the base of thor...
(A) Dose response profile of in vitro cell proliferation assay; (B) Dose response profile of recepto...
The approval of biosimilars requires demonstration of biosimilarity, which rests on the base of thor...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
(A) Overlay of SEC-HPLC chromatographic profile of INTP5, US Neulasta and EU Neulasta (Sample I2, U4...
(A) Overlay of RP chromatographic profile of INTP5, US Neulasta and EU Neulasta (Sample I2, U4 and E...
(A) Overlay of far UV CD spectra, (B) Overlay of FTIR spectra, (C) Overlay of fluorescence spectra, ...
(A) Representative RP-HPLC profile of stressed deamidated INTP5 (Sample I2) for peak collection. (Hi...
(A) Representative RP-HPLC profile of oxidized (24 hours) INTP5 Sample I2 (B) Overlay of control sam...
(A) TIC overlay of pegfilgrastim main peak and Pre-peak impurity (RRT 0.84) in peptide mapping (10–7...
(A) TIC overlay of pegfilgrastim main peak and Pre-peak impurity 1 (RRT 0.60) in peptide mapping (10...
The approval of biosimilars requires demonstration of biosimilarity, which rests on the base of thor...
(A) Dose response profile of in vitro cell proliferation assay; (B) Dose response profile of recepto...
The approval of biosimilars requires demonstration of biosimilarity, which rests on the base of thor...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...
Pegfilgrastim is administered as an adjunct to chemotherapy to reduce the incidence of febrile neutr...